Pharmacokinetics and renal handling of 99mTc-labeled peptides

Journal of Nuclear Medicine

Volumn 41, Issue 1, 2000, Pages 177-182

  Trejtnar, Frantisek ^a   Laznicek, Milan ^b   Laznickova, Alice ^b   Mather, Stephen J ^b  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b NONE

Author keywords

99mTc; Peptide complexes; Pharmacokinetics; Tetrapeptides

Indexed keywords

PEPTIDE DERIVATIVE; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ARTICLE; HYDROPHILICITY; ISOTOPE LABELING; KIDNEY PERFUSION; KIDNEY SCINTISCANNING; LIPOPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

ANIMALS; ISOTOPE LABELING; KIDNEY; MALE; ORGANOTECHNETIUM COMPOUNDS; PEPTIDES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0033958927     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Reubi JC, Kvols L, Krenning E, Lamberts SW. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism. 1990;39:78-81.
2. Krenning EP, Kwekkeboom DJ, Bakker WH. Somatostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I-123-Thr]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
3. Pearson DA, Lister-James J, McBride WJ, et al. Somatostatin receptor-binding peptides labelled with technetium-99m: chemistry and initial biological studies. J Med Chem. 1996;39:1361-1371.
4. Vallabhajosula S, Moyer BR, Lister-James J, et al. Preclinical evaluation of technetium-99m-labelled somatostatin receptor-binding peptides. J Nucl Med. 1996;37:1016-1022.
5. Mather SJ, Ellison D. Technetium radiolabelling of small receptor-binding peptides. Nucl Med Commun. 1993;14:280.
6. Yamaoka K, Tanigawara Z, Nakagawa T, Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J Pharm Dyn. 1981;4:879-885.
7. Laznickova A, Laznicek M, Kvetina J, Drobnik J. Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats. Cancer Chemother Pharmacol. 1986;17:133-136.
8. Mather SJ, Ellison D, Bard DS. Technetium-99m labelled hybrid receptor-binding peptides. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Padova, Italy: SG Editoriali; 1995:491-497.
9. 99mTc. Q J Nucl Med. 1996;40:221-233.
10. 99mTc-MAG. J Nucl Biol Med. 1994;38:69-74.
11. Vanbilloen HP, De Roo MJ, Verbruggen AM. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties. Eur J Nucl Med. 1996;23:40-48.
12. 99mTc-labelled agents. Nucl Med Biol. 1995;22:325-338.
13. Carone FA, Peterson DR, Flouret G. Renal tubular processing of small peptide hormones. J Lab Clin Med. 1982;100:1-14.
14. Leibach FH, Ganapathy V. Peptide transporters in the intestine and the kidney. Annu Rev Nutr. 1996;16:99-119.
15. Ross CR, Holohan PD. Transport of organic anions and cations in isolated renal plasma membranes. Annu Rev Pharmacol Toxicol. 1983;23:65-85.
16. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m-MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111-116.
17. Bubeck B, Brandau W, Weber E, Kuble T, Parekh N, Georgi P. Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med. 1990;31:1289-1293.